Adenovirus-thymidine kinase (Adv-TK) mediated delivery of herpes simplex viruses into tumour cells is one of the best studied gene therapy approaches to facilitate the killing of tumours[11], [12]. The gene discussed is TKT; the disease is neoplasm.